Combination Therapy With Entinostat and Pembrolizumab in Relapsed and Refractory Lymphomas
Part of paid clinical trials in Evanston, Illinois.
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study ID
- NCT03179930
- Phase
- PHASE2
- Status
- Active Not Recruiting
Conditions
- Lymphoma
- Refractory
- Relapsed
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Entinostat — DRUGAll patients will receive entinostat 5-7 mg PO as per the dosing regimen at the on D1, D8, and D15
- Pembrolizumab — DRUGpembrolizumab 200 mg IV on D1
Study Details
The purpose of this study is to test any good and bad effects of the study drugs called Pembrolizumab and Entinostat when used in combination to treat lymphoma. This combination could shrink the lymphoma but it could also cause side effects. Researchers also hope to learn whether adding entinostat to pembrolizumab can be more effective for patients with lymphoma than either drug alone.
Key Dates
- Start date
- Jun 7, 2017
- Status verified
- Jul 2025
- Primary completion
- Jun 30, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 47 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Entinostat and Pembrolizumabpatients will be assigned to receive therapy with entinostat given by mouth once weekly and pembrolizumab given intravenously every 3 weeks
Primary Outcome Measure
Response using the 2014 Lugano Classification [ Time Frame: 2 years ]
Locations (9)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Northwestern University (Data Collection Only) | Evanston | Illinois | 60208 | - |
| Memorial Sloan Kettering Basking Ridge | Basking Ridge | New Jersey | 07920 | - |
| Memorial Sloan Kettering Monmouth | Middletown | New Jersey | 07748 | - |
| Memorial Sloan Kettering Bergen | Montvale | New Jersey | 07645 | - |
| Roswell Park Cancer Institute (Data Collection Only) | Buffalo | New York | 14263-0001 | - |
| Memorial Sloan Kettering Commack | Commack | New York | 11725 | - |
| Memorial Sloan Kettering Westchester | Harrison | New York | 10604 | - |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | - |
| Memorial Sloan Kettering Nassau | Uniondale | New York | 11553 | - |
Find similar trials in Evanston, IL
By research site
Northwestern University (Data Collection Only)· Evanston, ILMemorial Sloan Kettering Basking Ridge· Basking Ridge, NJMemorial Sloan Kettering Monmouth· Middletown, NJMemorial Sloan Kettering Bergen· Montvale, NJRoswell Park Cancer Institute (Data Collection Only)· Buffalo, NYMemorial Sloan Kettering Commack· Commack, NY
Related Studies
- Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative DisordersRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and LymphomaRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)PHASE1/PHASE2 · Recruiting · Merck Sharp & Dohme LLC · Aurora, Colorado
- Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute LeukemiaRecruiting · Memorial Sloan Kettering Cancer Center · Hartford, Connecticut